133 related articles for article (PubMed ID: 17881654)
1. BNP is a transcriptional target of the short stature homeobox gene SHOX.
Marchini A; Häcker B; Marttila T; Hesse V; Emons J; Weiss B; Karperien M; Rappold G
Hum Mol Genet; 2007 Dec; 16(24):3081-7. PubMed ID: 17881654
[TBL] [Abstract][Full Text] [Related]
2. FGFR3 is a target of the homeobox transcription factor SHOX in limb development.
Decker E; Durand C; Bender S; Rödelsperger C; Glaser A; Hecht J; Schneider KU; Rappold G
Hum Mol Genet; 2011 Apr; 20(8):1524-35. PubMed ID: 21273290
[TBL] [Abstract][Full Text] [Related]
3. SHOX interacts with the chondrogenic transcription factors SOX5 and SOX6 to activate the aggrecan enhancer.
Aza-Carmona M; Shears DJ; Yuste-Checa P; Barca-Tierno V; Hisado-Oliva A; Belinchón A; Benito-Sanz S; Rodríguez JI; Argente J; Campos-Barros A; Scambler PJ; Heath KE
Hum Mol Genet; 2011 Apr; 20(8):1547-59. PubMed ID: 21262861
[TBL] [Abstract][Full Text] [Related]
4. Impairment of SHOX nuclear localization as a cause for Léri-Weill syndrome.
Sabherwal N; Schneider KU; Blaschke RJ; Marchini A; Rappold G
J Cell Sci; 2004 Jun; 117(Pt 14):3041-8. PubMed ID: 15173321
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation on Ser106 modulates the cellular functions of the SHOX homeodomain protein.
Marchini A; Daeffler L; Marttila T; Schneider KU; Blaschke RJ; Schnölzer M; Rommelaere J; Rappold G
J Mol Biol; 2006 Jan; 355(3):590-603. PubMed ID: 16325853
[TBL] [Abstract][Full Text] [Related]
6. New roles of SHOX as regulator of target genes.
Rappold GA; Durand C; Decker E; Marchini A; Schneider KU
Pediatr Endocrinol Rev; 2012 May; 9 Suppl 2():733-8. PubMed ID: 22946287
[TBL] [Abstract][Full Text] [Related]
7. Alteration of DNA binding, dimerization, and nuclear translocation of SHOX homeodomain mutations identified in idiopathic short stature and Leri-Weill dyschondrosteosis.
Schneider KU; Marchini A; Sabherwal N; Röth R; Niesler B; Marttila T; Blaschke RJ; Lawson M; Dumic M; Rappold G
Hum Mutat; 2005 Jul; 26(1):44-52. PubMed ID: 15931687
[TBL] [Abstract][Full Text] [Related]
8. Complete SHOX deficiency causes Langer mesomelic dysplasia.
Zinn AR; Wei F; Zhang L; Elder FF; Scott CI; Marttila P; Ross JL
Am J Med Genet; 2002 Jun; 110(2):158-63. PubMed ID: 12116254
[TBL] [Abstract][Full Text] [Related]
9. The short stature homeodomain protein SHOX induces cellular growth arrest and apoptosis and is expressed in human growth plate chondrocytes.
Marchini A; Marttila T; Winter A; Caldeira S; Malanchi I; Blaschke RJ; Häcker B; Rao E; Karperien M; Wit JM; Richter W; Tommasino M; Rappold GA
J Biol Chem; 2004 Aug; 279(35):37103-14. PubMed ID: 15145945
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone therapy in patients with short stature homeobox-gene (SHOX) deficiency.
Iughetti L; Madeo S; Predieri B
J Endocrinol Invest; 2010 Jun; 33(6 Suppl):34-8. PubMed ID: 21057184
[TBL] [Abstract][Full Text] [Related]
11. SHOX haploinsufficiency and its modifying factors.
Ogata T
J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1289-94. PubMed ID: 12510982
[TBL] [Abstract][Full Text] [Related]
12. Short stature caused by isolated SHOX gene haploinsufficiency: update on the diagnosis and treatment.
Jorge AA; Funari MF; Nishi MY; Mendonca BB
Pediatr Endocrinol Rev; 2010 Dec; 8(2):79-85. PubMed ID: 21150837
[TBL] [Abstract][Full Text] [Related]
13. NPPB and ACAN, two novel SHOX2 transcription targets implicated in skeletal development.
Aza-Carmona M; Barca-Tierno V; Hisado-Oliva A; Belinchón A; Gorbenko-del Blanco D; Rodriguez JI; Benito-Sanz S; Campos-Barros A; Heath KE
PLoS One; 2014; 9(1):e83104. PubMed ID: 24421874
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of SHOX deficiency.
Nicolosi A; Caruso-Nicoletti M
J Endocrinol Invest; 2010 Jun; 33(6 Suppl):7-10. PubMed ID: 21057178
[TBL] [Abstract][Full Text] [Related]
15. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome.
Rao E; Weiss B; Fukami M; Rump A; Niesler B; Mertz A; Muroya K; Binder G; Kirsch S; Winkelmann M; Nordsiek G; Heinrich U; Breuning MH; Ranke MB; Rosenthal A; Ogata T; Rappold GA
Nat Genet; 1997 May; 16(1):54-63. PubMed ID: 9140395
[TBL] [Abstract][Full Text] [Related]
16. SHOX triggers the lysosomal pathway of apoptosis via oxidative stress.
Hristov G; Marttila T; Durand C; Niesler B; Rappold GA; Marchini A
Hum Mol Genet; 2014 Mar; 23(6):1619-30. PubMed ID: 24186869
[TBL] [Abstract][Full Text] [Related]
17. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome).
Belin V; Cusin V; Viot G; Girlich D; Toutain A; Moncla A; Vekemans M; Le Merrer M; Munnich A; Cormier-Daire V
Nat Genet; 1998 May; 19(1):67-9. PubMed ID: 9590292
[TBL] [Abstract][Full Text] [Related]
18. SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability.
Jorge AA; Souza SC; Nishi MY; Billerbeck AE; Libório DC; Kim CA; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2007 Jan; 66(1):130-5. PubMed ID: 17201812
[TBL] [Abstract][Full Text] [Related]
19. The human SHOX mutation database.
Niesler B; Fischer C; Rappold GA
Hum Mutat; 2002 Nov; 20(5):338-41. PubMed ID: 12402330
[TBL] [Abstract][Full Text] [Related]
20. Expression of SHOX in human fetal and childhood growth plate.
Munns CJ; Haase HR; Crowther LM; Hayes MT; Blaschke R; Rappold G; Glass IA; Batch JA
J Clin Endocrinol Metab; 2004 Aug; 89(8):4130-5. PubMed ID: 15292358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
